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Lymph node lymphatic vessels (LNLVs) serve as
a conduit to drain antigens from peripheral tissues
to within the lymph nodes. LNLV density is known
to be positively regulated by vascular endothelial
growth factors secreted by B cells, macrophages,
and dendritic cells (DCs). Here, we show that LNLV
formation was negatively regulated by T cells. In
both steady and inflammatory states, the density of
LNLVs was increased in the absence of T cells but
decreased when T cells were restored. Interferon-g
secretion by T cells suppressed lymphatic-specific
genes in lymphatic endothelial cells and conse-
quently caused marked reduction in LNLV formation.
When T cells were depleted, recruitment of antigen-
carrying DCs to LNs was augmented, reflecting
a compensatorymechanism for antigen presentation
to T cells through increased LNLVs. Thus, T cells
maintain the homeostatic balance of LNLV density
through a negative paracrine action of interferon-g.
INTRODUCTION
Lymph nodes (LNs) are immunological junctions strategically sit-
uated throughout the mammalian body at sites where soluble
and cell-mediated antigens drain from peripheral tissues. At
these specific locations, the antigens are exposed to specific
lymphocytes, enabling the latter to generate adaptive immune
responses (Drayton et al., 2006; Gretz et al., 1997; Randolph
et al., 2005). LNs contain a network of lymphatic vessels (LVs)
that are used as a route for antigen delivery. The microstructure
of LNLVs consists of sinusoidal extensions that begin at the
peripheral afferent LVs, are further distributed just below the
capsule and surrounding B cell follicles, and stretch toward
the medullar region of LNs (Drayton et al., 2006; Mueller and
Germain, 2009). LNLVs function as specialized conduits for
carrying peripheral tissue-borne and cell-mediated antigen into96 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.physical proximity of the T cell zone. Thus, rapidly moving
T cells can encounter their specific antigen to initiate adaptive
immune responses (Alvarez et al., 2008; Catron et al., 2004; Itano
and Jenkins, 2003; Junt et al., 2008; von Andrian and Mempel,
2003). From this point of view, LNLVs are critical in providing
an interface between antigen-presenting cells (APCs) and
T cells. Therefore, it can be deduced that the density of LNLVs,
the number of T cells, or both might act as rate-limiting determi-
nants of antigen presentation and immune reaction initiation.
However, little is known about the relationship between LNLVs
and T cells in the complex micro-architecture of LNs.
We, along with several groups, have reported that peripheral
inflammation transiently induces robust lymphangiogenesis in
draining LNs (Halin et al., 2007; Kataru et al., 2009; Liao and
Ruddle, 2006). In the process of LN lymphangiogenesis, LNLVs
below the capsule proliferate, grow, and penetrate deep into
the cortex. This LN lymphangiogenesis is thought to bemediated
mostly by vascular endothelial growth factors (VEGFs), including
VEGF-A, -C, and -D secreted at the site of inflammation (Halin
et al., 2007; Kataru et al., 2009). Various intranodal cellular
components are deeply involved in the process of inflammatory
LN lymphangiogenesis by secreting VEGFs. For instance, during
the process of inflammation, intranodal B cells secrete VEGF-A
(Angeli et al., 2006) and CD11b+ macrophages migrated from
peripheral tissues secrete VEGFs, which promote intranodal
lymphangiogenesis (Kataru et al., 2009; Kim et al., 2009).
Furthermore, stromal fibroblastic reticular cells (FRCs) in LNs
are known to influence the LN vasculature by secreting VEGFs
in both homeostatic and inflammatory conditions (Chyou et al.,
2008). However, the role of T cells in regulating LNLVs has not
been clarified. Considering that T cells constitute more than
half of the total LN cellularity and are the major effector cells
that interact with DCs migrating through LVs, it is intriguing
whether they have any effect on LNLVs.
During acute inflammation, LN remodeling is characterized by
a transient increase in size, cellularity, lymph and blood flow,
blood vessel, and high endothelial venule density (Drayton
et al., 2006). LNLVs also expand transiently and regress back
to normal as inflammation resolves (Kataru et al., 2009).
However, there is little data regarding how the LNLVs expand
and retreat as inflammation evolves. We thought it would be
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between the regression of LNLVs and alterations of the profile
of lymphocyte populations during the resolving stage of inflam-
mation. In our study, we observed that as inflammation progress,
dynamic remodeling of LN microarchitecture takes place. At the
peak of inflammation, LNLVs were found to penetrate deep into
the T cell zone (paracortex and cortex), but once the inflamma-
tion had resolved, their regression was observed. Consequently,
LNLVs would have had to trespass the T cell zone during the
peak of inflammation, theoretically suggesting a possibility of
a yet unknown reciprocal influence that might define an intimate
relationship between LNLVs and the T cell population.
Interferon-g (IFN-g) is a pleiotropic cytokine secreted from
type 1 helper T (Th1) cells and plays a major role in initiating
cell-mediated adaptive immune responses as well as in modu-
lating cell growth and differentiation (Dalton et al., 1993). IFN-g
plays a vital role during viral infection in regulating the number
of T cells, particularly CD8+ T cells (Tewari et al., 2007; Whitmire
et al., 2005). Several reports indicate that IFN-g has a strong
antiangiogenic effect causing tumor blood vessel regression
(Fathallah-Shaykh et al., 2000; Gately et al., 1994; Ruegg et al.,
1998). Furthermore, the blood vessel regression observed during
tumor immunotherapy is mainly attributed to IFN-g secreted by
T cells located in and around the tumor microenvironment
(Ibe et al., 2001). However, the effect of IFN-g on LVs is poorly
understood with only limited in vitro data indicating that IFN-g
may have an antilymphangiogenic role (Shao and Liu, 2006).
Considering the strong antiangiogenic property of IFN-g and
the intersecting pathways of blood and lymphatic vessels, we
hypothesized that IFN-g could have an antilymphatic effect.
To test this hypothesis, we have analyzed LNLVs under several
T cell-deficient conditions. Our findings revealed that T cells
negatively regulate LNLVs, and IFN-g was deeply involved in
the process by acting as a strong antilymphatic component of
the LN microenvironment. Thus, in combination with the already
known prolymphatic effect of B cells, the antilymphatic role of
T cells that we describe here accounts for a balanced intranodal
regulatory mechanism that provides us with an insight on how
LNLV formation is controlled.
RESULTS
T Cell-Deficient Athymic Mice Have Abundant LNLVs
Normal mice cervical LN sections (Figure S1A available online)
were immunostained for CD33 (Pan T cell marker), B220 (B cell
marker), and LYVE-1 (lymphatic vessel marker) to delineate the
T cell zone, B cell zone, and LVs, respectively (Figure 1A; Fig-
ure S1B). LYVE-1+ LVs were observed mainly in the subcapsular
regions and extended to the medullary regions. In contrast, LVs
were very scarce or absent in the T cell-rich paracortex, which
occupied a considerable portion of the LNs (Figure S1B).
Higher-magnification images revealed that LVs were closely
associated to regions populated with B cells but not with
T cells (Figure S1C). This observation led us to question why
T cell-rich areas do not accommodate LVs.
To address the question, we explored the distribution profile of
LVs in T cell-deficient LNs retrieved from athymicmice. LNs from
four representative areas, namely cervical (cLN), inguinal (iLN),
mesenteric (mLN), and axillary (aLN) regions, were obtained.The LNs of athymic mice displayed a higher density of
LYVE-1+ LVs (2.4- to 3.9-fold higher) (Figures 1A and 1B), larger
size (Figure 1C), and the absence of T cells (Figure 1D) compared
to those of normal mice. To obtain quantitative measurements of
lymphatic endothelial cell (LEC) count in LNs, flow cytometry
analysis of dissociated LNs was performed (Figures 1E and
1F). The results of flow cytometry were reproducible in a profile
that positively correlated with our LNLV density measurements,
verifying the reliability of our immunohistochemical data. The
LNLVs of athymic mice densely covered the entire T cell-absent
LN paracortex, a corresponding region where LNLVs were
scarcely populated in normal mice (Figure 1A). Coimmunostain-
ing for Prox-1 (a master transcriptional factor of lymphatic differ-
entiation) and LYVE-1 revealed that the examined LYVE-1+
vessel-like structures were also Prox-1+, confirming their identity
as LVs (Figure 1G). These results suggest that the distribution of
LNLVs is inversely correlated with that of T cells.
CD4+ and CD8+ T Cells but Not B220+ B Cells Suppress
LNLVs
We wondered whether the LNLVs of athymic mice would
resemble those of normal mice if they were provided with
T cells. CD4+ and CD8+ T cells were obtained from ds-Red
(variant of red fluorescent protein) mice and each type of T cell
was independently transferred into athymic mice. For com-
parison, equal numbers of B220+ B cells from ds-Red mice
were adoptively transferred into athymic mice. Two days after
transfer, red fluorescent CD4+ or CD8+ cells around T cell zones
and B220+ cells at germinal center regions were found in all
major LNs, showing targeted homing of lymphocytes (Figure 2A).
In this condition, LNLVs were significantly diminished in the
areas occupied by either CD4+ or CD8+ ds-Red T cells
compared with the LNs of PBS-treated mice (20% and
31% reduction for CD4+ and CD8+ T cells, respectively)
(Figures 2A and 2B). However, the LV density around B cell
zones was similar between control and postadoptive transfer
of B220+ cells (Figure 2A). Flow cytometry analysis of dissoci-
ated LNs displayed a similar profile: the LEC count was signifi-
cantly decreased in mice in which either CD4+ or CD8+ T cells,
but not B220+ cells, were adoptively transferred (Figure 2C).
To administer specific stimuli, we pretreated B220+ B cells and
both T cell subsets with PMA and ionomycin and repeated the
adoptive transfer into athymic mice. Under this condition, the
decrease in the LNLV density caused by the stimulated T cell
subsets became more prominent (43% and 55% reduction
for CD4+ and CD8+ T cells, respectively). This pattern of LNLV
suppression was also observed by flow cytometry analysis;
LEC count decreased by adoptive transfer of either type of
T cells but not by B cells (Figures 2C and 2D). These data indicate
that adoptive transfer of T cells is sufficient to decrease LNLVs,
supporting the hypothesis that the presence of T cells correlates
with LNLV regression.
Reversible Changes of LNLVs after Depletion
and Restoration of T Cells
To further specify the suppressive role of T cells in LNLVs, we
induced T cell depletion (T-De) in LNs by treating the mice intra-
venously with anti-CD33 (1 mg/kg/day for 5 days). This proce-
dure successfully removed the T cells from LNs (90%Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc. 97
Figure 1. Athymic Nude Mice Have Abundant LNLVs
Cervical LNs (cLN, C), inguinal LNs (iLN, I), mesenteric LNs (mLN, M), and axillary LNs (aLN, A) were sampled from 8-week-old normal and athymic BALB/c mice.
(A) Representative immunohistochemistry images showing the distributions of CD33+ T cells, B220+ B cells, and LYVE-1+ LVs in the midsection of cLN from n = 5
in two independent experiments. Scale bars represent 500 mm.
(B) Comparison of LV density (LVD) (n = 5 per group in two independent experiments).
(C) Comparison of LN volume (n = 5 per group in two independent experiments).
(D) Comparison of numbers of T and B cells (n = 5 per group in two independent experiments).
(E) Flow cytometry analysis of the dissociated cLN for CD45 stromal cells (top) and gp38+CD31+ LEC population (bottom) (n = 3 per group in two independent
experiments).
(F) Comparison of LEC count per 1 3 106 LN cells (n = 3 per group in two independent experiments).
(G) Representative images showing LYVE-1+Prox-1+ LVs in the midsections of cLN from n = 3 in two independent experiments. Scale bars represent 50 mm.
The graphs show mean ± SD. *p < 0.05 versus normal. See also Figure S1.
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percentage significantly increased (3.7- and 3.1-fold increase
of LNLV density in cLN and mLN, respectively, compared to
the control group) (Figures 3A–3E) to resemble the profile of
LNs from athymicmice.We then askedwhether T cell restoration
(T-Re) could reverse the pattern of LNLVs back to baseline. After
anti-CD3e treatment, the mice were left untreated for 10 days to
allow T cell recovery (92% of control) (Figure 3B). As a result,
the LNLV pattern almost returned to the baseline state (Figures
3A, 3C, and 3E), indicating that T cells have negative influence
on LNLV growth.
Based on these findings, we speculated that one ormore cyto-
kines secreted by the T cells might interfere with LNLV growth.
Among the cytokines secreted by T cells, IFN-g is well known
for its antiangiogenic effect (Ruegg et al., 1998). Therefore, we
reasoned that the role of IFN-g could be overlapping in function
to cause an antilymphangiogenic effect and thusmay be respon-
sible for the T cell-mediated negative regulation of LNLV growth
as well. To investigate this possibility, quantitative real-time PCR
(qRT-PCR) of LN tissues was performed. Significant downregu-
lation of IFN-g mRNA in LNs of the athymic and T-De mice was98 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.observed, whereas no noticeable differences were detected
between T-Re and control mice (Figure 3F), suggesting that
the IFN-g amount in LNs is mainly determined by T cells and is
inversely correlated with the LNLV density. Meanwhile, the
mRNA expression of VEGF-A, -C, and -D was upregulated in
LNs of the athymic and T-De mice (Figure 3F) and positively
correlated with the LNLV density. The amount of IFN-g, which
correlates positively to the number of T cells but negatively to
the LNLV density, supports our hypothesis that T cell-secreted
IFN-g has an antilymphangiogenic effect. Immunostaining and
flow cytometry data revealed that LNs of athymic mice have
higher percentages of CD11b+ macrophages and CD11c+ DCs
compared to those of normal mice in steady state, suggesting
that the T cell-deficient condition may influence other immune
cell populations (Figure 3G). We interpreted this as the state of
increased LNLVs in athymic mice possibly harboring more
sinus-lining macrophages and DCs (Ohtani and Ohtani, 2008),
which in turn would secrete more VEGFs (Kataru et al., 2009;
Maruyama et al., 2005; Webster et al., 2006). Indeed, higher
regional concentrations of VEGFs were observed in the LNs (Fig-
ure 3F), although their source remains to be identified.
Figure 2. Suppression of LNLVs Occurs by
Adoptive Transfer of CD4+ and CD8+ T Cells
but Not of B220+ B Cells
5 3 107 cells of (unstimulated or stimulated with
PMA and ionomycin) CD4+ T cells (CD4), CD8+
T cells (CD8), or B220+ B cells (B220) from ds-Red
mice were adoptively transferred into athymic
nude mice. PBS was injected into control mice.
mLNs were sampled 2 days after transfer.
(A) Representative images showing the distribu-
tion of adoptively transferred cells (red) and
LYVE-1+ LVs in the midsections of mLNs from
n = 4 per group in two independent experiments.
Scale bars represent 500 mm.
(B) Comparison of LV density (LVD). Graph shows
mean ± SD (n = 4 per group in two independent
experiments). *p < 0.05 versus PBS; #p < 0.05
versus unstimulated.
(C) Comparison of LEC count by flow cytometry
analysis per 1 3 106 LN cells. Graph shows
mean ± SD (n = 3 per group in two independent
experiments). *p < 0.05 versus PBS.
(D) Representative flow cytometry analysis of the
percentage of CD31+/gp38+ LECs after adoptive
transfer of the stimulated cells (n = 3 per group in
two independent experiments).
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and Tumor
Wealsomodulated the number and ratio of T andB cells by treat-
ment with two inflammatory agents, LPS and Concanavalin-A
(Con-A). LPS (15 mg per treatment) or Con-A (15 mg per treatment)
was injected into the dorsal side of the ear skin and changes of
LNLVs were examined in the draining cLN. At the peak of inflam-
mation (3 days after injection), LPS robustly increased LNLVs
(3.1-fold), LEC percentage, and upregulated VEGFs mRNA
(2-, 1.7-, 2.4-fold increase of VEGF-A, -C, and -D, respectively,
compared to PBS control), but Con A failed to increase the LNLV
density and LEC percentage in cLN despite its successful induc-
tion of strong peripheral inflammation and upregulation of VEGFs
(2.7-, 1.2-, 3-fold increase of VEGF-A, -C, and -D, respectively,
compared to PBS control) (Figures 4A–4C; Figure S2A). In fact,
the total number of lymphocytes increased to a comparable
degree between LPS and Con-A treatments, but the T cell/B
cell ratio was higher in the Con-A-treated group compared with
the LPS-treated group (1.57 versus 0.39) (Figure 4D). Intriguingly,
Con-A,but not LPS,profoundlyupregulated IFN-gmRNAexpres-
sion (Figure 4C). Moreover, IFN-g concentration in the cell super-
natant of LN tissue obtained from mice treated with Con-A were
highly elevated, but not with PBS or LPS (Figure S2B).
Similar to inflammation, primary tumor is known to cause
increased LNLVs in the regional LNs (Hirakawa et al., 2007; To-
bler and Detmar, 2006). Therefore, we examined LNLV density in
the Lewis lung carcinoma (LLC) implantation model. As ex-
pected, the ipsilateral regional iLN displayedmarkedly increased
LYVE-1+ LVs, which occupied the entire T cell zones (Figure 4E).
Simultaneously, a significant reduction in the total number of LN
T cells was also noticed (62.5% reduction compared to normalLNs) (Figures 4F and 4G), reflecting an inverse relationship
between LNLV density and the number of T cells.
LNLV Regression Is Attenuated by Adoptive Transfer
of T Cells from IFN-g-Deficient Mice
To determine the effect of IFN-g on LNLVs in vivo, mice were
intradermally treated with 3 mg of IFN-g twice a day for 4 days
into the ear skin. After treatment, the draining LNs were exam-
ined to measure LNLV density. IFN-g treatment slightly but
significantly reduced the LNLV density compared with PBS
treatment (30% reduction) (Figures S3A and S3C). The number
of Prox-1+ LECs per LV was significantly reduced upon IFN-g
treatment (50%) (Figures S3B and S3D). Notably, Prox-1
expression was downregulated in a considerable portion of the
observed LECs in the LNs treated with IFN-g (Figure S3B).
Because we recognized IFN-g as a candidate molecule
responsible for LNLV suppression, we next performed adoptive
transfer with either unstimulated or stimulated T cell subsets
labeled with CFDA-SE green fluorescent that was derived from
IFN-g-deficient (Ifng/) mice into athymic mice. Green fluores-
cence was detected in the LNs, indicating that successful
homing of T cells had occurred. Unlike the potent LV suppres-
sion observed by the adoptive transfer of normal T cells (Figures
2A and 2B), Ifng/ T cells failed to completely inhibit the LNLVs
and remaining LVs were observed at modest frequency
(Figure 5A). The overall LNLV density failed to achieve statisti-
cally significant difference when compared with PBS-treated
control (Figure 5B). However, LNLV suppression still occurred
in areas where Ifng/ T cells were heavily populated. These
results indicate that IFN-g critically participates in the process
of T cell-mediated LNLV suppression but also implies thatImmunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc. 99
Figure 3. Reversible Changes of LNLVswith
Depletion and Restoration of T Cells
BALB/c mice were intravenously injected with
anti-CD33 (1 mg/kg/day) or hamster anti-mouse
IgG isotype Ab (Control) for 5 days to induce
T cell depletion (T-De) and then were left untreated
for 10 days to allow T cell restoration (T-Re).
Cervical LN (cLN, C) and mesenteric LN (mLN,
M) were sampled at day 5 (Control and T-De)
and 15 (T-Re) after antibody injection.
(A) Representative images showing the distribu-
tion of CD33+ T cells, B220+ B cells, and
LYVE-1+ LV in the midsections of mLN from n =
5 in two independent experiments. Scale bars
represent 500 mm.
(B) Comparison of numbers of T and B cells (n = 5
per group in two independent experiments).
*p < 0.05 versus control; #p < 0.05 versus T-De.
(C) Comparison of LV density (LVD) (n = 5
per group in two independent experiments).
*p < 0.05 versus control; #p < 0.05 versus T-De.
(D) Comparison of LN volume (n = 5 per group in
two independent experiments). *p < 0.05 versus
control.
(E) Representative flow cytometry analysis of the
percentage of CD31+/gp38+ LECs in the cLN
(n = 4 per group in two independent experiments).
(F) Comparison of mRNA expressions of IFN-g,
VEGF-A, -C, and -D in the cLNs. Data are pre-
sented as relative fold to control after standardiza-
tion with GAPDH (n = 4 per group in two indepen-
dent experiments). *p < 0.05 versus normal.
(G) Representative images showing the distribu-
tion of LYVE-1+ LVs, CD11b+ macrophages, and
CD11c+ DCs in the midsections of cLNs in
untreated normal and athymic mice from three
independent experiments. Scale bars represent
50 mm. Histograms showing populations of
CD11b+ macrophages and CD11c+ DCs in the
cLNs of untreated normal and athymic mice
(n = 4 per group in two independent experiments).
The graphs show mean ± SD.
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process.
Postinflammatory LNLV Regression Is Attenuated
in IFN-g-Deficient Mice
We next explored the status of LNLVs in Ifng/mice. Four major
LNs of Ifng/ mice were coimmunostained for LYVE-1 and
PECAM-1. Compared with wild-type, all LNs from Ifng/ mice
displayed an increase in LNLV density (1.7-fold), but no differ-
enceswere observed in blood vessel density (Figure 5C and data
not shown). The profiles of T and B cell populations of Ifng/
mice were similar to those of wild-type mice in normal condition.
To examine the effect of inflammation on LNLVs upon IFN-g defi-
ciency, Ifng/ mice were intradermally injected with LPS into
the peripheral ear skin. Three days after LPS treatment (during
the peak of inflammation), cLN from both wild-type and Ifng/100 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.mice displayed a similar increase in LNLV density (3.3- and
3.5-fold in wild-type and Ifng/, respectively) (Figures 5C
and 5D). Simultaneously, the ratio of T cells to B cells was signif-
icantly decreased in wild-type, but not in Ifng/, mice (Fig-
ure 5E). Twelve days after LPS treatment (during the resolving
stage of inflammation), the increased LNLV density observed
at 3 days after LPS injection had been significantly reduced in
wild-type mice, whereas those of the Ifng/ mice remained
persistently increased (Figures 5C and 5D). These data indicate
that IFN-g is an important mediator with a suppressive effect on
LNLVs during the baseline state and resolving stage of
inflammation.
IFN-g-Mediated LNLV Suppression Is a Primary Event
If we assume that the T cells maintain a constitutive negative-
feedback signal to the prolymphangiogenic drive known to be
Figure 4. Alterations of LNLV Density by
Modulations of T and B Cell Populations
(A–D) BALB/c mice were intradermally injected
with PBS, LPS (15 mg), or Con-A (15 mg) into the
dorsal side of the ear. cLNs were sampled
3 days after injection.
(A) Representative images showing distributions
of CD33+ T cells, B220+ B cells, and LYVE-1+
LVs in the midsections of cLNs from n = 5 in two
independent experiments. Scale bars represent
500 mm.
(B) Comparison of LV density (LVD) (n = 5
per group in two independent experiments).
*p < 0.05 versus PBS or Con-A.
(C) Comparison of VEGF-A, -C, -D, and IFN-g
mRNA level in cLN. Data are presented as relative
fold to PBS after normalization with GAPDH (n = 4
per group in two independent experiments).
*p < 0.05 versus PBS; #p < 0.05 versus LPS and
PBS.
(D) Comparison of numbers of T and B cells. Each
group, n = 5. *p < 0.05 versus PBS; #p < 0.05
versus LPS (n = 5 per group in two independent
experiments).
(E–G) 1 3 106 LLC tumor cells were subcutane-
ously injected into the flank region of C57BL/6J
mice. Tumor-draining iLNs were sampled 4 weeks
after tumor implantation for immunohistochem-
istry and flow cytometric analysis.
(E) Representative images showing the spatial
distribution of CD33+ T cells, B220+ B cells, and
LYVE-1+ LVs in the midsections of iLNs from n =
4 in two independent experiments. Scale bars
represent 500 mm.
(F) Comparison of numbers of T and B cells (n = 4
per group in two independent experiments).
*p < 0.05 versus normal.
(G) Tabular form of pie diagrams indicating the T
and B cell populations in affected LNs from four
different models in which the lymphocyte popula-
tion is altered. Decreased T cell to B cell ratio
correlates with higher LNLV density in all four
models.
The graphs show mean ± SD. See also Figure S2.
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state of LNLVs we observed during various conditions of T cell
depletion could simply be explained by a secondary enforce-
ment of the prolymphangiogenic drive. Therefore it is important
to identify whether the T cell-induced LNLV suppression we
describe is a real primary phenomena or merely the outcome
of secondary negative feedback to the prolymphangiogenic
stimuli. To clarify this matter, we performed a set of bonemarrow
transplantions that would intercept the signal transduction of
IFN-g by selectively removing the IFN-g receptor from either
the hematopoietic cells or nonhematopoietic cells, respectively,
by using IFN-gR1-deficient (Ifngr1/) donor and wild-type (WT)
recipient (Ifngr1/:WT) or vice versa (WT:Ifngr1/). Three days
after LPS injection into the ear, marked lymphangiogenesis was
observed in both types of bone marrow transplanted mice. After
12 days, however, only the Ifngr1/:WT mice demonstrated
LNLV regression similar to baseline, whereas the LNLVs ofWT:Ifngr1/ remained increased (Figures 6A and 6B). This indi-
cates that the interference of IFN-g signaling to prolymphangio-
genic hematopoietic cells do not inhibit the ability to suppress
LNLVs, but depriving the signaling to the nonhematopoietic cells
(which include LECs) do. Therefore, the mechanism of IFN-g-
mediated LNLV inhibition is through direct effect that cannot
be interpreted as the secondary weakening of prolymphangio-
genic stimuli generated by B cells, macrophages, and DCs.
To further specify the functional independence of the effect of
IFN-g and exclude the possibility of a compensatory involvement
of the prolymphangiogenic hematopoietic cells being the major
mechanism of LNLV suppression, we conducted an adoptive
transfer experiment in which the IFN-g receptors only of B cells
but not of T cells were selectively deleted. We performed
a double adoptive transfer with T cells from dsRed mice and B
cells from Ifngr1/ mice labeled with CFDA-SE into Rag1/
mice (which are deficient of both T and B cells). Three days afterImmunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc. 101
Figure 5. Adoptive Transfer of Ifng–/– T Cells
Shows Incomplete LNLV Suppression, and
the LNLV Regression Is Attenuated during
Inflammation Resolution in the Ifng–/– Mice
(A and B) 5 3 107 cells of purified CD4+ T cells
(CD4) and CD8+ T cells (CD8) either unstimulated
or stimulated with PMA and ionomycin from
Ifng/ mice were labeled with CFDA-SE and
adoptively transferred to athymic nude mice.
PBS was injected as negative control. mLNs
were sampled 2 days after transfer.
(A) Representative images showing the distribu-
tion of adoptively transferred cells (green) and
LYVE-1+ LVs in the midsections of mLNs from
n = 4 in two independent experiments. Scale
bars represent 500 mm. Regions densely popu-
lated with T cells (indicated as white dotted line
square in each inset) were viewed under high
magnification.
(B) Comparison of LV density (LVD) (n = 4 per
group in two independent experiments).
(C–E) Wild-type and Ifng/ BALB/c mice were
intradermally injected with LPS (15 mg) into the
dorsal side of the ear. cLNs were sampled 1 day
before (control) and 3 (LPS-3d) and 12 (LPS-12d)
days after injection.
(C) Representative images showing the distribu-
tion of LYVE-1+ LVs and PECAM-1+ blood vessels
in the midsections of cLNs from n = 4 in two inde-
pendent experiments. Scale bars represent
500 mm.
(D) Comparison of LV density (LVD) (n = 4
per group in two independent experiments).
*p < 0.05 versus wild-type.
(E) Comparison of numbers of T and B cells (n = 4
per group in two independent experiments).
*p < 0.05 versus B cells in Ifng/.
The graphs show mean ± SD. See also Figure S3.
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a diffused increase of LNLVs in the control (PBS only transferred)
Rag1/ mice. In contrast, strong suppression of LNLV was
observed in regions where T cells reside in the double adoptive
transferred Rag1/ mice (Figures 6C and 6D), indicating that
T cells can still achieve LV inhibition even under conditions in
which B cells cannot be provoked by IFN-g. Thus, the action of
IFN-g is independent of B cell activity.
IFN-g Negatively Regulates Prox-1 Expression in LECs
Based on the inhibitory effect of T cells via IFN-g on LNLVs
observed in vivo, we expanded our investigation to the effect
of T cells on primary cultured LECs in vitro. To confirm that
IFN-g mediates LV suppression, we examined LV sprouting
and growth in vitro by 3-dimensional culture of LVs from mouse
thoracic duct (TD) rings implanted into Matrigel (Bruyere et al.,
2008). In control TD rings, sprouting tips were seen around 3 to
4 days after implantation, and robust growth of LVs from the102 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.TD ring was observed around 7–8 days.
Coculturing TD rings with stimulated
normal T cells resulted in very few sprouts
and the majority failed to grow into vessel
structures. In contrast, TDs coculturedwith Ifng/ T cells demonstrated modest sprouting and growth
of LVs, but was not as robust as the negative control (Figures
S4A and S4B). This indicates that the antilymphangiogenic effect
of T cells occurs in an IFN-g-dependent fashion, but also implies
that pathways other than IFN-gmay be involved in this process.
We also used a cell culture insert system to coculture LECswith
either CD4+CD8+ T cells or CD19+ B cells prestimulated for IFN-g
production. After 2 days of coculture, LECswith the T cells but not
B cells showed dramatically elongated cell morphology on
aphasecontrastmicroscope (FigureS4C). Interestingly, immuno-
cytochemistry and qRT-PCR of LECs demonstrated reduced
protein and mRNA expression of Prox-1 when cocultured with
either CD4+ or CD8+ T cells but not with CD19+ B cells (Figures
S4C and S4D). Blocking Ab against IFN-g partially restored LEC
Prox-1 mRNA expression (Figure S4D).
To further dissect the mechanisms underlying the antilym-
phatic effect of IFN-g, we treated recombinant IFN-g to primary
cultured human dermal LECs, which actively expressed both
Figure 6. IFN-g-Mediated LNLV Inhibition Is a Primary Event
(A and B) WT:Ifngr1/ and Ifngr1/:WT BM transplantedmice were intradermally injected with LPS (15 mg) into the dorsal side of the ear. cLNs were examined 3
(LPS-3d) and 12 (LPS-12d) days after injection.
(A) Representative images showing the distribution of LYVE-1+ LVs and PECAM-1+ blood vessels in themidsections of cLNs from n = 5 in two independent exper-
iments. Scale bars represent 500 mm.
(B) Comparison of LV density (LVD) (n = 5 per group in two independent experiments). *p < 0.05 versus WT:Ifngr1/.
(C and D) 33 107 cells of purified T cells (ds-Red) and Ifngr1/ B cells (CFDA-SE labeled) were adoptively transferred to Rag1/mice (Rag1/ +DAT; double
adoptive transfer). PBS was injected as negative control (Rag1/ +PBS). LPS (15 mg) was injected intradermally into the dorsal side of the ear to all mice. cLNs
were sampled 3 days (LPS-3d) after LPS injection.
(C) Representative images showing the distribution of LYVE-1+ LVs, ds-Red+ T cells, and CFDA-SE-labeled B cells (yellow arrows) in the midsections of cLNs
from n = 4 per group in two independent experiments. Scale bars represent 500 mm.
(D) Comparison of LV density (LVD) (n = 4 per group in two independent experiments). Each group, n = 4. *p < 0.05 versus Rag1/ +PBS.
The graphs show mean ± SD.
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Suppressive Role of T Cells in Lymphatic GrowthIFN-g receptor-1 (IFNGR1) and IFNGR2 (Figure S4E). The mRNA
expression of IRF1, an IFN-g-responsive transcription factor
(Schroder et al., 2004), was highly upregulated (13.2-fold) after
IFN-g treatment, reflecting the responsiveness of LECs to IFN-g
(data not shown). IFN-g at a concentration of 1 mg/ml did not
show a measureable cytotoxic effect on LECs (Figure S4F), but
markedly elongated extensions of actin stress fibers were
observed 24 hr after treatment (Figure 7A). Immunocytochem-
istry demonstrated a considerable reduction of Prox-1 signal in
the IFN-g-treated LECs (Figure 7A). Immunoblot analyses
confirmed that the Prox-1 protein was reduced with IFN-g treat-
ment (Figure 7B). Correspondingly, themRNA of Prox-1 was also
decreased by IFN-g treatment in a dose-dependent manner
(Figure 7C), indicating that IFN-g negatively regulates the
expression of Prox-1 at the transcriptional level. In addition to
Prox-1, mRNA of several LEC-specific genes, such as LYVE-1
and podoplanin, were also suppressed by IFN-g (Figures 7D
and 7E). However, downregulation of Prox-1 rapidly occurred
within 2 hr after IFN-g treatment, whereas the suppression of
LYVE-1 and podoplanin was observed after 24 hr (data not
shown). These results suggest that IFN-g acts as a suppressorof lymphatic growth by downregulating the expression of LEC-
specific genes.
We next investigated several potential signaling pathways that
might be involved in this IFN-g-induced downregulation of
Prox-1. Previous studies have shown that various signaling
pathways, including MAPK, ERK, PI3K, IKK, and JAK-STAT,
can be stimulated by IFN-g (Gough et al., 2008; Schroder
et al., 2004). Therefore, we pretreated LECs with specific in-
hibitors that are known to block each signaling pathway and
searched for any alterations in the IFN-g-induced Prox-1 down-
regulation. Only piceatannol, a JAK1 inhibitor (Geahlen and
McLaughlin, 1989), selectively blocked the IFN-g-induced
Prox-1 downregulation in a dose-dependent manner, whereas
PI3K, MEK, or IKK inhibitors did not show significant influence
over the IFN-g-induced Prox-1 downregulation (Figures S4G
and S4H). These data indicate JAK1 as a crucial participant of
the signaling pathway mediating the IFN-g-dependent Prox-1
downregulation observed in LECs. Because a major down-
stream effecter of JAK1 is the STAT1 transcription factor, we
examined whether STAT1 is also involved in the IFN-g-induced
Prox-1 downregulation. We used (-)-epigallocatechin-3-gallateImmunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc. 103
Figure 7. IFN-g Negatively Regulates Prox-
1 Expression in LECs and In Vitro Lymphan-
giogenesis
(A–E) Primary cultured human dermal LECs were
treated with PBS, BSA (1 mg/ml/day), or IFN-g
(1 mg/ml/day) every 24 hr for 3 days and were
sampled.
(A) Left: Phase contrast images showing LEC
morphology from n = 3 in two independent exper-
iments. Scale bars represent 50 mm. Middle and
right: Confocal images showing Prox-1, actin,
and DAPI in LECs. Scale bars represent 20 mm.
(B) Immunoblotting for Prox-1 expression in PBS-,
BSA-, and IFN-g-treated LECs from n = 3 per
group in two independent experiments.
(C) Semiquantitative RT-PCR for Prox-1 mRNA
after IFN-g treatment in two concentrations
(n = 3 per group in two independent experiments).
(D) Semiquantitative RT-PCR for Prox-1, LYVE-1,
podoplanin (Podo), and GAPDH mRNAs (n = 3
per group in two independent experiments).
(E) Comparison of Prox-1, LYVE-1, and podopla-
nin mRNA levels from IFN-g-treated LECs via
quantitative RT-PCR. Data are presented as rela-
tive folds to PBS-treated control group after stan-
dardization with GAPDH (n = 4 per group in two
independent experiments). *p < 0.05 versus PBS.
(F and G) About 3 3 104 LECs were seeded into
Matrigel with or without IFN-g (1 mg/ml) and
IFN-g blocking Ab (5 mg/ml) and were incubated
for 24 hr.
(F) Representative phase contrast images of LEC
tube formation assay with media each added
with PBS, IFN-g alone, or IFN-g in combination
with IFN-g-blocking Ab from n = 4 per group in
two independent experiments. Scale bars repre-
sent 50 mm.
(G) Comparison of the total length of tube forma-
tion (exceeding 20 mm in diameter), calculated
from 10 random field images from each individual
experiment (n = 4 per group in two independent
experiments). *p < 0.05 versus PBS; #p < 0.05
versus IFN-g.
(H and I) Excised rings of thoracic ducts (TD) were
implanted into Matrigel and cultured for 2 weeks
with normal condition media alone or with media plus IFN-g (1 mg/ml), with or without IFN-g-blocking Ab (5 mg/ml) on day 0 and day 7 and incubated for 2 weeks.
(H) Representative phase contrast images showing lymphatic sprouts from n = 4 per group in two independent experiments. Scale bars represent 50 mm.
(I) Comparison of number of lymphatic sprouts (exceeding 20 mm length) per TD (n = 4 per group in two independent experiments). *p < 0.05 versus PBS; #p < 0.05
versus IFN-g.
The graphs show mean ± SD. See also Figures S4 and S5.
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of STAT1 but not STAT3 (Tedeschi et al., 2002). Pretreatment
of EGCG significantly restored the immunoreactivity and
mRNA expression of Prox-1 that was suppressed by IFN-g.
In contrast, pretreatment of (-)-epigallocatechin (EGC), a struc-
turally similar chemical to EGCG, failed to reverse the IFN-g-
induced Prox-1 downregulation (Figures S4I and S4J). Collec-
tively, these results demonstrate that the JAK1-STAT1 pathway
is critically involved in the IFN-g-mediated Prox-1 downregula-
tion in LECs.
IFN-g Negatively Regulates In Vitro Lymphangiogenesis
We next examined the effect of IFN-g on tube formation of LECs
in vitro. Successful tube formation was observed as early as 6 hr104 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.after plating LECs on Matrigel-coated dishes in normal growth
condition. However, adding IFN-g (1 mg/ml) to freshly plated
LECs caused a decrease in tube formation (80% reduction
compared with PBS-treated controls) for at least 24 hr (Figures
7F and 7G). Reversibly, IFN-g-neutralizing antibody suppressed
the inhibitory effect of IFN-g on tube formation (Figures 7F and
7G). It has been previously reported that budding and sprouting
of LECs require Prox-1 function (Wigle and Oliver, 1999). There-
fore, to further corroborate the antilymphangiogenic effect of
IFN-g, we examined the effect of IFN-g on LV sprouting and
growth in vitro by 3-dimensional culture of LVs from mouse
thoracic duct (TD) rings implanted into Matrigel (Bruyere et al.,
2008). Without adding IFN-g, sprouting tips were seen around
3 to 4 days after implantation, and robust growth of LVs from
Immunity
Suppressive Role of T Cells in Lymphatic Growththe TD ring was observed around 7–10 days. However, providing
IFN-g at a concentration of 1 mg/ml completely inhibited the LV
sprouting and growth from TD rings; this inhibitory effect was
rescued by adding IFN-g-neutralizing Ab (Figures 7H and 7I).
The IFN-g-treated TD rings started to sprout and grow normally
into vessel structures after replacing the media without IFN-g
(data not shown), indicating that IFN-g-dependent inhibition of
LV sprouting and growth is a reversible process.
Increased LNLV Density Promotes the Recruitment
of Antigen-Carrying DCs
Because the increase of LNLVs was reported to stimulate DC
recruitment into LNs (Angeli et al., 2006), we wondered whether
the state of highly dense LNLVs induced by T cell deficiency
could promote the recruitment of antigen-carrying DCs. Ear
drainage to the cLNs of athymic and normal control mice was
examined 2 days after 1 mm fluorescent microspheres were
intradermally injected into the ear. In the control cLNs, themicro-
spheres were densely distributed mostly along the LYVE-1+ LVs
of the subcapsular area but were only scarcely found in the
cortical regions (Figure S5A). In contrast, cLNs in athymic mice
showed abundant microspheres both in the cortical regions
and along the LYVE-1+ LVs of the subcapsular area, suggesting
that the microspheres in the LNs of athymic mice migrated rela-
tively deeper into the paracortex and cortex compared with
those in control mice (Figure S5A). In the cortical regions of
cLNs in athymic mice, a fair amount of the microspheres were
colocalized with CD11c+ DCs, indicating the presence of micro-
sphere-carrying DCs in these regions (Figure S5A). Most of these
microsphere-carrying DCs were in close contact with the dense
LYVE1+ LNLVs, suggesting that LNLVs are major conduits for
these antigen-carrying DCs. These data suggest a scenario
where the absence of T cells leads to an increase in LNLV
density, which thereby facilitates the physical interaction
between antigen-carrying DCs and less populated T cells
(Figure S5B).
DISCUSSION
Here we provide evidence that the T cells negatively regulate
LNLVs mainly through IFN-g. We also suggest a scenario where
the antilymphatic T cells maintain a homeostatic balance against
their counterpart prolymphatic B cells, and that the T/B cell ratio
is a key modulating factor that determines the LNLV density. If
the T cell-dependent antilymphatic drive is weakened because
of a decline of intranodal T cell count as shown in our study,
a relative augmentation of prolymphatic components would
occur even without necessarily increasing their quantities.
Consequently, the homeostatic balance would be shifted toward
a state of excessive secretion of B cell-derived VEGFs that is
unopposed, tilting the balance toward the direction of overall
promotion of LNLV growth. However, T cell-mediated LNLV
suppression is the primary event instead of a mere endpoint of
compensation, as shown by the fact that T cells still accomplish
LNLV inhibition when B cells were unresponsive to IFN-g.
An example of our hypothesis is the change in LNLVs
observed in inflammatory models. Our results demonstrated
that LPS-mediated acute inflammation induced an increase in
the B cells/T cells ratio that was accompanied by LNLV growthand penetration into T cell zones. In contrast, Con-A (T cell
mitogen)-mediated acute inflammation failed to promote the
growth of LNLVs, despite strong inflammatory reactions at the
ear skin and increased B cell number and VEGFs in LNs.
However, Con-A induced a robust proliferation of both T cells
and B cells in a parallel manner, and thus the T/B cell ratio was
maintained relatively constant to the basal level with a concurrent
and balanced increase of pro- and antilymphangiogenic factors.
These results strengthen our proposed concept that the negative
regulation by T cells is deeply involved in themechanism causing
an increase of LNLVs during inflammation. We then questioned
whether the LPS-induced increase of LNLVs would regress
back to the basal state as inflammation subsides and, if so,
whether the altered T cell/B cell ratio could serve as a direct
cause for such an effect. Given that the T cell/B cell ratio is
minimal whereas LNLV density is maximal at the peak of inflam-
mation, and vice versa for both preinduction and postresolution
of inflammation, we deduce the T cells are involved in not only
the growth but also the regression of LNLVs during the evolution
of inflammation. Similar observations in the draining LNs of
arthritic joints displaying decreased T cells (Rodriguez-Palmero
et al., 1999) and increased LNLVs (Guo et al., 2009) were re-
ported during the latent period of arthritis in different rodent
models. Collectively, we consider the entire process as a balance
between prolymphatic and antilymphatic components that is
roughly represented by the T cell/B cell ratio; this hypothesis is
supported by our observations in athymic mice, pharmacologi-
cally T-De and T-Re mice, LPS- or Con-A-induced inflammation
models, and experimental tumor-implanted mice.
In our study, we tried to dissect the molecule(s) and signaling
pathway(s) the T cells adopt to regulate LNLVs. We consider
IFN-g as our most important candidate, because Ifng/ mice
showed an increased baseline amount of LNLVs, and the further
enhanced growth of LNLVs induced by acute inflammation failed
to subside during the resolving stage of inflammation. However,
as we have demonstrated by the adoptive transfer and TD ring
coculture with T cells derived from Ifng/ mice, the inactivation
of IFN-g alone cannot completely neutralize the T cell-mediated
antilymphatic effect. This suggests that other yet unknown T cell-
originating factors probably also participate in LNLV suppression
and may compensate for the absence of IFN-g. We hope that
subsequent studies will further elucidate other involved signaling
pathways.
We also showed that IFN-g treatment causes the downregula-
tion of Prox-1, LYVE-1, and podoplanin in LECs and strongly
repress lymphatic sprouting and growth in vitro. Prox-1, a major
LEC-specific transcription factor, plays an important role in the
survival, maintenance, and proliferation of LECs (Johnson
et al., 2008; Petrova et al., 2002; Tammela and Alitalo, 2010;
Wigle and Oliver, 1999). Multiple effects of IFN-g in regulating
the process of immunity are known to be modulated through
the JAK-STAT pathway (Hu and Ivashkiv, 2009). Consistently,
our results show that the effects of IFN-g on LECs are mediated
through serial events of signaling by IFN-g via IFNGR1 and/or
IFNGR2, JAK, and STAT1 phosphorylation, suggesting that
JAK1-STAT1 signaling is a pivotal pathway involved in the
IFN-g-mediated Prox-1 downregulation.
Another important finding of this study is that the elevated LV
density in T cell-deficient LNs promoted the recruitment ofImmunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc. 105
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to facilitate the physical interaction between antigen-carrying
DCs and their corresponding T cells (Catron et al., 2004; Itano
and Jenkins, 2003; von Andrian and Mempel, 2003). Unlike in
normal mice, in the athymic mice we observed both the antigen
and antigen-carrying DCs being abundantly distributed
throughout the entire LNLV, including those situated in the
deep cortex. This indicates that enhanced LNLVs subjected to
the environment of T cell insufficiency promote the recruitment
of antigen and antigen-carrying DCs. Similar to the aforemen-
tioned B cell-dependent growth of LNLVs and subsequent
recruitment of DCs, these serial events can be interpreted as
a dynamic feedback circuit designed to offer more opportunities
to the DCs tomeet the less populated T cells. Furthermore, it has
been recently reported that LECs have a function of presenting
endogenous antigen and are involved in the modulation of
peripheral immune tolerance (Cohen et al., 2010). This implies
that the T cells may serve as one of the biological moderators
to orchestrate the entire immune system by regulating LNLVs.
In conclusion, our findings shed light on the previously
unknown role of T cells being a major regulator of LNLVs. Both
the T cells and B cellsmodulate the LNLV density but in opposing
directions. In the steady state of theLNmicroenvironment, Bcells
and APCs enhance LNLV growth through soluble factors such as
VEGFs, whereas T cells suppress LNLV growth via soluble
factors like IFN-g to maintain the balance at homeostasis.
However, a condition causing a decline in the T cell/B cell ratio,
such as in acute inflammation, upsets the balance between the
two opposite forces and promotes LNLV growth. This event
would promote the subsequent recruitment of antigen-carrying
DCs, allowing more efficient interaction with the less populated
T cells.We also identified IFN-g secreted by T cells as an antilym-
phatic growth cytokine, which downregulates lymphangiogenic
molecules, such as Prox-1, in LECs. Considering the importance
of LNLVs in many aspects of immunity, our findings of LNLVs
being regulated by T cells may be applied to develop more effi-
cient vaccines or widen our knowledge in fields of immune-
compromised pathologies and autoimmune disorders.
EXPERIMENTAL PROCEDURES
Mice and Treatments
Specific-pathogen-free C57BL/6J, BALB/c, athymic nude mice (BALB/c,
CbyJ.Cg-Foxn1nu/J), ds-Red fluorescent mice (C57BL/6J), Ifng/ mice
(C57BL/6J and BALB/c), Ifngr1/ mice (C57BL/6J), and Rag1/ mice
(C57BL/6J) were purchased from Jackson Laboratory and bred in our path-
ogen-free animal facility. All animals were fed with a standard normal diet
(PMI Lab Diet) ad libitum with free access to water. Seven- to eight-week-
old male mice were used for this study unless otherwise specifically indicated.
Animal care and experimental procedures were performedwith the approval of
the Animal Care Committee of KAIST.
Flow Cytometric Analysis and Histological and Morphologic
Analyses
Flow cytometric analysis of LNs, fluorescent immunohistochemistry of LN
tissue sections, and immunocytochemistry of cultured LECs were performed
with specific primary and secondary antibodies as described in detail in
Supplemental Experimental Procedures.
Purification of Lymphocytes for Adoptive Transfer
Spleens from ds-Red or Ifng/ or Ifngr1/mice were excised and single-cell
suspensions were prepared by pulverizing the spleens against a 40 mm nylon106 Immunity 34, 96–107, January 28, 2011 ª2011 Elsevier Inc.cell strainer into FACS buffer. RBCs were lysed with RBC lysis buffer (Sigma-
Aldrich). Cells werewashedwithMACS buffer and countedwith a hemocytom-
eter, and equal numbers of cells were incubated with biotin-conjugated anti-
mouse CD4, CD8, CD33, and B220 antibodies (BD Biosciences) for 30 min
on ice. Cells were washed two to three times and incubated with magnetic-
conjugated biotin Ab (Miltenyi Biotec) for 20 min on ice. CD4+, CD8+, CD33+,
or B220+ cell populations were enriched with a magnetic cell sorter (MACS)
(Miltenyi Biotec) according to the manufacturer’s instructions. The purities of
the cells were more than 93% according to flow cytometric analysis. Then
the cells were stimulated with PMA (10 ng/ml) (Sigma-Aldrich) and ionomycin
(200 ng/ml) (Sigma-Aldrich) for 2 hr in a 5%CO2 incubator for IFN-g production
(whenever necessary). 5 3 107 cells of the stimulated or unstimulated CD4+,
CD8+, CD33+, or B220+ cells were adoptively transferred intravenously into
athymic nude or Rag1/ mice via the tail vein. Two days after transfer, all
major LNs were isolated for subsequent analyses.
Reagent Treatments
Systemic depletion of T cells (T-De) was performed by intravenous administra-
tion of anti-mouse CD33 monoclonal Ab (1 mg/kg/day for 5 days; Clone 145-
2C11; ATCC). As a control, the same amount of hamster anti-mouse IgG
isotype Ab (R&D Systems) was administered in the same manner. After Ab
treatment, the mice were left without any further treatment for 10 days to allow
T cell restoration (T-Re). For generation of acute inflammation in the ear skin,
a single injection of LPS (15 mg in 10 ml PBS) (from Escherichia coli 0111:B4,
Sigma-Aldrich) or Con-A (15 mg in 10 ml PBS; Sigma-Aldrich) was intradermally
administered with a 31-gauge syringe (BD ultra-fine II, Becton, Dickinson and
Company) into the dorsal side of the ear. Ear-draining cLNs were collected at
the indicated day. To examine the effect of IFN-g in vivo, 3 mg of recombinant
mouse IFN-g (R&D Systems) was intradermally administered twice a day for
4 days into the dorsal side of the ear.
Cell Culture, Reagent Treatment, and Visualizing Antigen Mobility
in LNs
These procedures were performed as described in detail in Supplemental
Experimental Procedures.
Statistics
Values are presented as mean ± standard deviation (SD). Significant differ-
ences between means were determined by an analysis of variance followed
by the Student-Newman-Keuls test. Statistical significance was set at
p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/j.
immuni.2010.12.016.
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